Triactiv FX Embolic Protection System
Temporary Coronary Saphenous Vein Bypass Graft For Embolic Protection. 510(k) K061772, from Kensey Nash Corp. (Exton, PA). Product code NFA, class 2.
As of Nov 20, 2026, K061772 is an FDA 510(k) held by Kensey Nash Corp., substantially equivalent on Jul 11, 2006 after 18 days, with 3 recalls tied to it in FDA's recall database.
- Review time: 18 days
- Recalls: 3
- Cited as a predicate by: 1 device
The TriActiv FX® Embolic Protection System is indicated for use in conjunction with percutaneous coronary intervention (PCI), using a 7F guide catheter (without side holes), of diseased saphenous vein coronary bypass grafts ranging from 3.0mm to 5.0m in diameter.
- Triactiv SystemK042040 · Kensey Nash Corp. · Mar 23, 2005
- Triactiv FX Embolic Protection System, Model PN 60040-02; -03K062870 · Kensey Nash Corp. · Oct 20, 2006
| Started | Recall | Status |
|---|---|---|
| Mar 28, 2007 | Z-0835-2007, Z-0833-2007, Z-0834-2007Insufficient wire sealing | Terminated |
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 23, 2006
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files